Malaysian Re & China Re Life sign reinsurance treaty for Cancer Precision Medicine coverage
Jun 19th, 2026 • 5 min • View Source
Malaysian Reinsurance Berhad (Malaysian Re), Malaysia’s national reinsurer, and China Reinsurance Life Insurance Company Limited (China Re Life), a life and health reinsurer, have signed a landmark reinsurance treaty to support a dedicated framework for Cancer Precision Medicine (CPM) treatment coverage in Malaysia. This marks Malaysia’s first reinsurance framework for advanced cancer treatments, including CAR-T […] The post Malaysian Re & China Re Life sign reinsurance treaty for Cancer Precision Medicine coverage appeared first on ReinsuranceNe.ws.
Commercial risk teams are responding with tighter controls, scenario modeling, and broader collaboration across underwriting, claims, and cyber operations.
Leaders continue to prioritize resilience planning while balancing cost, coverage terms, and operational exposure in a changing market cycle.